PLAU and hepatocellular carcinoma: At low concentrations, resveratrol treatment (25–100 μM) inhibited the metastasis of HCC cells and decreased expression of urokinase-type plasminogen activator (u-PA), which involved downregulation of the SP-1 signaling pathway [112].